Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Fluorimetric determination of the levels of urinary neopterin and serum thiobarbituric acid reactive substances in the nonagenarians

Dagmar Solichová, Bohuslav Melichar, Miloš Klejna, Božena Jurášková, Lucie Královská, Vladimír Bláha, Petr Žďánský, Zdeněk Zadák

. 2003 ; 60 (2-3) : 459-465.

Language English Country Netherlands

Grant support
NG6770 MZ0 CEP Register
NC6171 MZ0 CEP Register

Twelve self-sustaining nonagenarians, 10 women and two men, aged 94+/-3 years, and eight institutionalised nonagenarians, eight women, aged 91+/-1 year as well as 11 control subjects, seven women and four men, aged 84+/-5 years entered the study. Urinary neopterin, an indicator of systemic immune activation, and serum thiobarbituric acid reactive substances (TBARS), a marker of lipoperoxidation, were determined initially, and collection of the blood and urine samples was repeated at 3-month interval. Neopterin was measured in the urine specimens by reversed-phase high performance liquid chromatography. A C(18) reversed-phase column 3.3x150 mm, 5 mum-diameter packing Separon SGX was used. Potassium phosphate buffer (15 mmol l(-1), pH 6.4) at flow rate of 0.8 ml min(-1) was used as mobile phase. After centrifugation (5 min, 1300xg) and diluting 100 mul of urine specimens with 1.0 ml of mobile phase containing 2 g of disodium-EDTA per litre, a 20 mul sample was injected on a column. Neopterin was identified by its native fluorescence (353 nm excitation, 438 nm emission). Creatinine was determined by Jaffé kinetic reaction after dilution of sample 1:50 (v/v). The concentration of neopterin in urine was expressed as neopterin/creatinine ratio (mumol mol(-1) creatinine). TBARS were determined spectrofluorometrically using LS-5 spectrofluorimeter (excitation wavelength 528 nm, emission wavelength 558 nm) after extraction with n-butanol treatment with thiobarbituric acid. The significance of differences between nonagenarians and control group was examined by ANOVA-Kruskal-Wallis tests, using statistical software NCSS 6.0.21 (Kaysville, UT, 1996). The decision on significance was based on P=0.05. Urinary neopterin was significantly higher in institutionalised compared to self-sustaining subjects and controls (625+/-565 vs. 203+/-63 mumol mol(-1) creatinine, and 198+/-128 mumol mol(-1) creatinine, respectively, P=0.006). The serum TBARS were higher in both groups of nonagenarians (3.23+/-1.16 mumol l(-1) and 2.69+/-0.39 vs. 2.12+/-0.83 mumol l(-1) for the self-sustaining, institutionalised and controls, respectively, P=0.023). We conclude that the fluorimetric determinations of urinary neopterin and serum TBARS can be useful for the monitoring health status in the elderly patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12035834
003      
CZ-PrNML
005      
20130709080143.0
007      
ta
008      
121106s2003 ne f 000 0eng||
009      
AR
024    __
$a 10.1016/s0039-9140(03)00073-0 $2 doi
035    __
$a (PubMed)18969067
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Solichová, Dagmar $7 xx0060526 $u Department of Metabolic Care and Gerontology, Charles University Medical School, Teaching Hospital, 500 05 Hradec Králové, Czech Republic
245    10
$a Fluorimetric determination of the levels of urinary neopterin and serum thiobarbituric acid reactive substances in the nonagenarians / $c Dagmar Solichová, Bohuslav Melichar, Miloš Klejna, Božena Jurášková, Lucie Královská, Vladimír Bláha, Petr Žďánský, Zdeněk Zadák
520    9_
$a Twelve self-sustaining nonagenarians, 10 women and two men, aged 94+/-3 years, and eight institutionalised nonagenarians, eight women, aged 91+/-1 year as well as 11 control subjects, seven women and four men, aged 84+/-5 years entered the study. Urinary neopterin, an indicator of systemic immune activation, and serum thiobarbituric acid reactive substances (TBARS), a marker of lipoperoxidation, were determined initially, and collection of the blood and urine samples was repeated at 3-month interval. Neopterin was measured in the urine specimens by reversed-phase high performance liquid chromatography. A C(18) reversed-phase column 3.3x150 mm, 5 mum-diameter packing Separon SGX was used. Potassium phosphate buffer (15 mmol l(-1), pH 6.4) at flow rate of 0.8 ml min(-1) was used as mobile phase. After centrifugation (5 min, 1300xg) and diluting 100 mul of urine specimens with 1.0 ml of mobile phase containing 2 g of disodium-EDTA per litre, a 20 mul sample was injected on a column. Neopterin was identified by its native fluorescence (353 nm excitation, 438 nm emission). Creatinine was determined by Jaffé kinetic reaction after dilution of sample 1:50 (v/v). The concentration of neopterin in urine was expressed as neopterin/creatinine ratio (mumol mol(-1) creatinine). TBARS were determined spectrofluorometrically using LS-5 spectrofluorimeter (excitation wavelength 528 nm, emission wavelength 558 nm) after extraction with n-butanol treatment with thiobarbituric acid. The significance of differences between nonagenarians and control group was examined by ANOVA-Kruskal-Wallis tests, using statistical software NCSS 6.0.21 (Kaysville, UT, 1996). The decision on significance was based on P=0.05. Urinary neopterin was significantly higher in institutionalised compared to self-sustaining subjects and controls (625+/-565 vs. 203+/-63 mumol mol(-1) creatinine, and 198+/-128 mumol mol(-1) creatinine, respectively, P=0.006). The serum TBARS were higher in both groups of nonagenarians (3.23+/-1.16 mumol l(-1) and 2.69+/-0.39 vs. 2.12+/-0.83 mumol l(-1) for the self-sustaining, institutionalised and controls, respectively, P=0.023). We conclude that the fluorimetric determinations of urinary neopterin and serum TBARS can be useful for the monitoring health status in the elderly patients.
650    _2
$a neopterin $x moč $7 D019798
650    _2
$a látky reagující s kyselinou thiobarbiturovou $x analýza $7 D017392
650    _2
$a senioři $7 D000368
650    _2
$a lidé $7 D006801
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fluorometrie $7 D005470
700    1_
$a Melichar, Bohuslav, $d 1965- $7 skuk0000853 $u Department of Oncology and Radiotherapy, Charles University Medical School, Teaching Hospital, 500 05 Hradec Králové, Czech Republic
700    1_
$a Klejna, Miloš $7 xx0070786 $u Hospital for Chronically Ill, Hradec Králové, Czech Republic
700    1_
$a Jurašková, Božena, $d 1956- $7 mzk2004258479 $u Department of Metabolic Care and Gerontology, Charles University Medical School, Teaching Hospital, 500 05 Hradec Králové, Czech Republic
700    1_
$a Královská, Lucie $u Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic
700    1_
$a Bláha, Vladimír, $d 1964- $7 xx0002944 $u Department of Metabolic Care and Gerontology, Charles University Medical School, Teaching Hospital, 500 05 Hradec Králové, Czech Republic
700    1_
$a Žďánský, Petr, $d 1942- $7 xx0076498 $u Department of Metabolic Care and Gerontology, Charles University Medical School, Teaching Hospital, 500 05 Hradec Králové, Czech Republic
700    1_
$a Zadák, Zdeněk, $d 1937- $7 nlk19990074064 $u Department of Metabolic Care and Gerontology, Charles University Medical School, Teaching Hospital, 500 05 Hradec Králové, Czech Republic
773    0_
$t Talanta $x 0039-9140 $g Roč. 60, č. 2-3 (2003), s. 459-465 $w MED00004484
910    __
$a ABA008 $y 2
990    __
$a 20121106095439 $b ABA008
991    __
$a 20130709080605 $b ABA008
999    __
$a ok $b bmc $g 957762 $s 793354
BAS    __
$a 3
BMC    __
$a 2003 $b 60 $c 2-3 $d 459-465 $x MED00004484 $i 0039-9140 $m Talanta
GRA    __
$a NG6770 $p MZ0
GRA    __
$a NC6171 $p MZ0
LZP    __
$a 2012-11/lmlm

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...